Matthew Young - Nutanix VP Japan
| 0NU Stock | EUR 61.88 0.64 1.02% |
Insider
Matthew Young is VP Japan of Nutanix
| Phone | 408 216 8360 |
| Web | https://www.nutanix.com |
Matthew Young Latest Insider Activity
Tracking and analyzing the buying and selling activities of Matthew Young against Nutanix stock is an integral part of due diligence when investing in Nutanix. Matthew Young insider activity provides valuable insight into whether Nutanix is net buyers or sellers over its current business cycle. Note, Nutanix insiders must abide by specific rules, including filing SEC forms every time they buy or sell Nutanix'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Matthew Young over six months ago Acquisition by Matthew Young of 20000 shares of CytomX Therapeutics subject to Rule 16b-3 | ||
Matthew Young over a year ago Acquisition by Matthew Young of 25000 shares of CytomX Therapeutics subject to Rule 16b-3 | ||
Matthew Young over a year ago Payment of 1348 shares by Matthew Young of Jazz Pharmaceuticals subject to Rule 16b-3 |
Nutanix Management Efficiency
The company has return on total asset (ROA) of (0.1054) % which means that it has lost $0.1054 on every $100 spent on assets. This is way below average. Nutanix's management efficiency ratios could be used to measure how well Nutanix manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Francois LocohDonou | F5 Networks | 52 | |
| Jacques Kerrest | Okta Inc | 45 | |
| Matthew Smith | Amdocs Limited | 51 | |
| Amir Hermelin | Fair Isaac | N/A | |
| Alvina Antar | Okta Inc | 47 | |
| Brett Tighe | Okta Inc | 42 | |
| Eugenio Pace | Okta Inc | N/A | |
| Tamar RapaportDagim | Amdocs Limited | 52 | |
| Susan Ledger | Okta Inc | 58 | |
| Rob Gruening | F5 Networks | N/A | |
| James Wehmann | Fair Isaac | 58 | |
| Mark Scadina | Fair Isaac | 54 | |
| Richard Deal | Fair Isaac | 56 | |
| Michael Leonard | Fair Isaac | 58 | |
| Darcy Antonellis | Amdocs Limited | N/A | |
| Chad Esq | F5 Networks | 51 | |
| Don Peterson | Fair Isaac | 61 | |
| Idit Aronsohn | Amdocs Limited | N/A | |
| Michael McLaughlin | Fair Isaac | 58 | |
| Suzanne DuLong | F5 Networks | N/A | |
| Stephanie Covert | Fair Isaac | 43 | |
Management Performance
| Return On Asset | -0.11 |
Nutanix Leadership Team
Elected by the shareholders, the Nutanix's board of directors comprises two types of representatives: Nutanix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nutanix. The board's role is to monitor Nutanix's management team and ensure that shareholders' interests are well served. Nutanix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nutanix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Sangster, Executive Vice President - Operations | ||
| Rajiv Ramaswami, CEO Pres | ||
| Anja Hamilton, Chief Officer | ||
| Matthew Young, VP Japan | ||
| Mandy Dhaliwal, Chief Officer | ||
| Rukmini Sivaraman, Principal CFO | ||
| Ajeet Singh, CoFounder Advisor | ||
| Wendy Pfeiffer, Chief Officer | ||
| Tyler Wall, Chief Officer | ||
| Tonya Chin, VP IR |
Nutanix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nutanix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.11 | |||
| Profit Margin | (0.29) % | |||
| Operating Margin | (0.24) % | |||
| Current Valuation | 7.32 B | |||
| Shares Outstanding | 230.11 M | |||
| Shares Owned By Insiders | 2.08 % | |||
| Shares Owned By Institutions | 81.10 % | |||
| Price To Sales | 4.40 X | |||
| Revenue | 1.58 B | |||
| Gross Profit | 1.26 B |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Nutanix Stock
When determining whether Nutanix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nutanix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nutanix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nutanix Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nutanix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Nutanix Stock please use our How to Invest in Nutanix guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.